$CHD

Is Stronger-Than-Expected Q2 Demand and Higher 2026 Guidance Altering The Investment Case For Church & Dwight (CHD)?

Church & Dwight (CHD) reported stronger-than-expected Q2 2026 demand, beating sales forecasts and raising its full-year outlook for net sales, organic sales, adjusted EPS, and gross margins. Management's confidence is reflected in higher guidance, though risks like input cost inflation and category pressure remain. The company maintains a quarterly dividend of $0.3075 per share.

Original reporting
Published Aug 20, 2026, 5:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Stronger-Than-Expected Q2 Demand and Higher 2026 Guidance Altering The Investment Case For Church & Dwight (CHD)? — source image
Decision brief

The 30-second read

$CHDBullishHigh
01

Why it matters

The guidance lift signals resilient demand and margin improvement, offering a buying opportunity.

02

Market read

Earnings beat with guidance raise is a primary catalyst for CHD and may influence the consumer‑staples sector.

03

What to watch

Input‑cost inflation and underperforming beauty brands may temper upside.

Relevance 8/10Novelty 8/10Timing: immediate post‑earnings release

Background

Church & Dwight (CHD) reported Q2 2026 results, beating forecasts and raising its 2026 outlook.

Company-level read

Ticker impact

$CHDBullishHigh confidence
Context

Q2 2026 earnings beat and raised full-year 2026 guidance for sales, EPS and margins.

Expected impact

Potential short-term rally; target price may rise 5‑7% on the news.

Evidence & confidence

Guidance lift is material and fresh; investors typically reward improved outlook for a stable consumer staple.

Market effects

May lift other consumer‑staples peers as demand outlook improves.

Positive for U.S. consumer‑goods sector.

Limited to household products segment.

Counterpoint

Rising retailer power and promotional intensity could pressure margins despite guidance.

Key entities

  • Church & Dwight

    Household and personal care products manufacturer.

Related articles

$CHDMed

CHD Chemicals Q1 Results: Net loss widens 20% YoY to ₹12.3 lakh

CHD Chemicals reported a wider Q1 FY27 net loss of ₹12.27 lakh, down from ₹15.43 lakh in Q1 FY26. Revenue from operations rose 28% YoY to ₹162.42 lakh, but total expenses increased 17% to ₹175.15 lakh. Other income fell to ₹0.46 lakh from ₹7.90 lakh. EPS remained negative at about ₹-0.12. Results were approved Aug 14, 2026.

$CHDMedAI 8/10

Church & Dwight (CHD) Q2 2026 Earnings Call Transcript

Church & Dwight (CHD) reported Q2 2026 net sales of $1.5 billion, up 1.6%, with organic sales growth of 5.8% driven by 4.3% volume and 1.5% price and mix. Adjusted EPS was $0.89, above its $0.88 outlook. The company raised full-year guidance for organic sales (4% to 5%) and adjusted EPS (6% to 8%).

$CHDMed

Read Analyst Questions From Church & Dwight’s Q2 Earnings Call

Church & Dwight reported Q2 revenue of $1.53B, slightly above analyst estimates of $1.50B, and adjusted EPS of $0.89, in line with expectations. Management cited 5.8% organic revenue growth, strong demand for ARM & HAMMER, THERABREATH, and HERO, and early momentum from the MISS MOUTH acquisition. Q3 adjusted EPS guidance is $0.89 at the midpoint, below estimates of $0.94.

$CHDMedAI 8/10

Church & Dwight Boosts FY26 Outlook - Update

Church & Dwight (CHD) reported Q2 results and raised its FY2026 outlook. For Q3, it expects adjusted EPS of $0.89 with net sales down about 1% and organic sales up about 3%. For FY2026, it now projects earnings growth of 20% to 22% and adjusted earnings growth of 6% to 8% on net sales growth of 0% to 1%, with organic sales up 4% to 5%.

$CHDMed

Church & Dwight (NYSE:CHD) Surprises With Q2 CY2026 Sales

Church & Dwight (NYSE:CHD) reported Q2 CY2026 sales of $1.53 billion, up 1.6% year on year and above analysts’ estimates by 1.8%, according to the company. Non-GAAP profit was $0.89 per share, in line with consensus. The firm said it is raising its sales, EPS, and cash flow outlook, and organic sales rose 5.8% y/y.